Microwave zaps prostate tumors with 3D precision in new trial
NCT ID NCT04582656
First seen Apr 23, 2026
Summary
This study tested a new treatment that uses 3D mapping to guide microwaves and destroy only the main tumor in men with intermediate-risk prostate cancer. 76 men from Europe took part. The goal was to see if the cancer was gone one year later, without needing more aggressive treatments like full gland removal or radiation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
American Hospital of Paris
Neuilly-sur-Seine, 92200, France
-
Centre Hospitalier Universitaire de Bordeaux
Bordeaux, 33000, France
-
Hôpital Cochin (Assistance Publique - Hôpitaux de Paris)
Paris, 75014, France
-
Institut Jules Bordet
Brussels, 1000, Belgium
-
Urologie Nantes Clinique & Institut d'Urologie - Site Atlantis
Saint-Herblain, 44800, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.